-
2026-10-28
IND Approval: GenSci136 Advances into Sj?gren's SyndromeLearn More
-
2026-10-22
Phase 3 trial in China successfully confirms ACARIZAX? safety and efficacy in patients with house dust mite allergyLearn More
-
2026-10-10
GenSci's Oncology Innovation: NDA Approval Secured for Prostate CancerLearn More
-
2026-10-09
GenSci's Two Innovations Received IND Clearance from NMPALearn More
-
2026-09-03
GenSci Showcases Innovation at CPHI Korea 2026Learn More
-
2024-09-24
Meet GenSci at CPhI Milan 2024Learn More
-
2024-09-23
GenSci showcases the innovative pipelines at ChinaBio?Learn More
-
2024-09-03
GenSci Invites You to Meet Us at Pharmedi Vietnam 2024Learn More
-
2024-08-29
GenSci098 Injection Obtains Implied License For Clinical Trials of FDALearn More
-
2024-08-21
Jintrolong? New Dosage Form of Long-acting Somatropin Injection ApprovedLearn More
-
2024-08-06
Clinical Trial Commencement of GenSci098 Injection ApprovedPreclinical data indicate GenSci098 has the potential to become a new treatment for Thyroid Eye Disease
Learn More